News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
GlaxoSmithKline Opens Cape Town Drug Plant
November 4, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
GlaxoSmithKline has opened a new $3 million facility in Cape Town, South Africa, that will produce medicine to treat the debilitating disease lymphatic filariasis.
Twitter
LinkedIn
Facebook
Email
Print
Real estate
Africa
GSK
MORE ON THIS TOPIC
ADC Therapeutics
ADC Therapeutics lays off 17% of global workforce
June 24, 2026
·
63 min read
·
BioSpace Editorial Staff
Manufacturing
Jubilant draws FDA rebuke for delayed mold investigation and quality unit lapses
June 24, 2026
·
2 min read
·
Nick Paul Taylor
Layoffs
ADC Therapeutics lays off staff after 27 patient deaths mar Zynlonta readout
June 24, 2026
·
2 min read
·
Gabrielle Masson
Duchenne muscular dystrophy
REGENXBIO bets on FDA flexibility with filing plans for Duchenne gene therapy
June 24, 2026
·
2 min read
·
Gabrielle Masson
